"Designing Growth Strategies is in our DNA"

Degenerative Disc Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Type {Conventional Drugs (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Opioids, and Others), Novel Therapies (Cell Therapy, Platelet Rich Plasma (PRP), and Others)}, and Regional Forecast, 2022-2029

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI107102

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence: Chronic Lower Back Pain, Degenerative Disc Diseases, Key Countries/ Region, 2020/2021
    2. Pipeline Analysis, Key Players
    3. New Product Launches, by Key Players
    4. Key Industry Developments - Mergers & Acquisitions
    5. Impact of COVID-19 on the Market
  5. Global Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others
    2. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of World Degenerative Disc Disease Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Conventional Drugs
        1. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        2. Corticosteroids
        3. Opioids
        4. Others
      2. Novel Therapies
        1. Cell Therapy
        2. Platelet Rich Plasma (PRP)
        3. Others (transforming growth factor beta (TGFβ) receptor antagonist, etc.)
  10. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Pfizer Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Eli Lilly and Company
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Ferring B.V.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. FibroGenesis
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. DiscGenics, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. SpineBioPharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  Global Degenerative Disc Disease Treatment Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 2:  Global Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021 & 2029

Figure 3:  Global Degenerative Disc Disease Treatment Market Value Share (%), By Region, 2021 & 2029

Figure 4:  North America Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 5:  North America Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 6:  North America Degenerative Disc Disease Treatment Market Value (USD billion), By Country, 2021 & 2029

Figure 7:  North America Degenerative Disc Disease Treatment Market Value Share (%), By Country, 2021

Figure 8:  Europe Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 9:  Europe Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 10:  Europe Degenerative Disc Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 11:  Europe Degenerative Disc Disease Treatment Market Value Share (%), By Country/ Sub-region, 2021

Figure 12:  Asia Pacific Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 13:  Asia Pacific Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 14:  Asia Pacific Degenerative Disc Disease Treatment Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 15:  Asia Pacific Degenerative Disc Disease Treatment Market Value Share (%), By Country/ Sub-region, 2021

Figure 16:  Rest of the World Degenerative Disc Disease Treatment Market Value (USD billion), by Type, 2021 & 2029

Figure 17:  Rest of the World Degenerative Disc Disease Treatment Market Value Share (%), by Type, 2021

Figure 18:  Global Degenerative Disc Disease Treatment Market Share (%), By Company, 2021

Table 1:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 2:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 3:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 4:  Global Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Region, 2018-2029

Table 5:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 6:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 7:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 8:  North America Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, By Country, 2018-2029

Table 9:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 10:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 11:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 12:  Europe Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 13:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 14:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 15:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Table 16:  Asia Pacific Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 17:  Rest of the World Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Type, 2018-2029

Table 18:  Rest of the World Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Conventional Drugs, 2018-2029

Table 19:  Rest of the World Degenerative Disc Disease Treatment Market Revenue (USD billion) Forecast, by Novel Therapies, 2018-2029

Degenerative Disc Disease Treatment Market Size, Share and Global Industry Trend Forecast till 2029
  • 2018-2029
  • 2021
  • 2018-2020
  • 102
Consulting Services
    How will you benefit from our consulting services ?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports